Исследование влияния остеофильного бисфосфонатного полимера на пролиферацию, остеогенную дифференцировку адипозных мезенхимальных стволовых клеток и изучение его способности ингибировать активность остеокластов in vitro

Translated title of the contribution: Cell therapy approach for correction of osteoporosis-associated fractures using adipose-derived mesenchymal stem cells functionalized with osteophilic polymer

Research output: Contribution to journalArticle

Abstract

Osteoporosis is a progressive systemic skeletal disease characterized by reduced bone density and disrupted microarchitecture of the bone tissue that leads to increased bone fragility and elevated risk of bone fractures. In osteoporotic condition decrease in bone density and strength happens not only due to the increased osteoclastic activity but also due to the decreased number of osteoblast cells precursors (mesenchymal stem cells) and development of so called “osteogenic insufficiency”. We proposed the new method of cell therapy with adipose derived mesenchymal stem cells (AT-MSCs) and surface modification with synthetic bisphosphonate osteophilic polymer that would restore the osteoblast progenitor pool and at the same time inhibit osteoclastic activity in the regeneration zone of osteoporosis associated fractures. In current paper we have outlined the process of osteophilic polymer synthesis, isolation of homogenic population of AT-MSCs and assessment of the purity of obtained cell populations, assessment of polymer effect on cell proliferation and subsequent differentiation down the osteogenic lineage and polymer effect on the osteoclastic activity in vitro. According to the obtained data polymer was not found to be cytotoxic and did not affect the speed of MSCs proliferation. Surface modification with the polymer has no effect on cell osteogenic differentiation however inhibits phagocytic activity of bone marrow derived macrophages. Polymer functionalized MSCs could be subsequently used in further animal studies to assess the efficacy of suggested approach for stimulation of regenerative processes in vivo using the animal model of osteoporosis and osteoporosis associated fractures of compact bones.
Original languageRussian
Pages (from-to)58-72
JournalExperimental Biology
Volume77
Issue number4 (2018)
Publication statusPublished - 2018

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Osteoporosis
Polymers
Osteoblasts
Bone Density
Bone and Bones
Bone Fractures
Diphosphonates
Population
Regeneration
Cell Differentiation
Animal Models
Cell Count
Macrophages
Cell Proliferation

Keywords

  • osteoporosis
  • osteoclasts
  • reparative osteogenesis
  • adipose mesenchymal stem cells
  • osteophilic polymer
  • cell therapy

Cite this

@article{242d4c208b224c928c233f219812abb1,
title = "Исследование влияния остеофильного бисфосфонатного полимера на пролиферацию, остеогенную дифференцировку адипозных мезенхимальных стволовых клеток и изучение его способности ингибировать активность остеокластов in vitro",
abstract = "Osteoporosis is a progressive systemic skeletal disease characterized by reduced bone density and disrupted microarchitecture of the bone tissue that leads to increased bone fragility and elevated risk of bone fractures. In osteoporotic condition decrease in bone density and strength happens not only due to the increased osteoclastic activity but also due to the decreased number of osteoblast cells precursors (mesenchymal stem cells) and development of so called “osteogenic insufficiency”. We proposed the new method of cell therapy with adipose derived mesenchymal stem cells (AT-MSCs) and surface modification with synthetic bisphosphonate osteophilic polymer that would restore the osteoblast progenitor pool and at the same time inhibit osteoclastic activity in the regeneration zone of osteoporosis associated fractures. In current paper we have outlined the process of osteophilic polymer synthesis, isolation of homogenic population of AT-MSCs and assessment of the purity of obtained cell populations, assessment of polymer effect on cell proliferation and subsequent differentiation down the osteogenic lineage and polymer effect on the osteoclastic activity in vitro. According to the obtained data polymer was not found to be cytotoxic and did not affect the speed of MSCs proliferation. Surface modification with the polymer has no effect on cell osteogenic differentiation however inhibits phagocytic activity of bone marrow derived macrophages. Polymer functionalized MSCs could be subsequently used in further animal studies to assess the efficacy of suggested approach for stimulation of regenerative processes in vivo using the animal model of osteoporosis and osteoporosis associated fractures of compact bones.",
keywords = "osteoporosis, osteoclasts, reparative osteogenesis, adipose mesenchymal stem cells, osteophilic polymer, cell therapy",
author = "Farkhad Olzhayev",
year = "2018",
language = "Russian",
volume = "77",
pages = "58--72",
journal = "Experimental Biology",
issn = "1563-0218",
publisher = "al-Farabi Kazakh State National University",
number = "4 (2018)",

}

TY - JOUR

T1 - Исследование влияния остеофильного бисфосфонатного полимера на пролиферацию, остеогенную дифференцировку адипозных мезенхимальных стволовых клеток и изучение его способности ингибировать активность остеокластов in vitro

AU - Olzhayev, Farkhad

PY - 2018

Y1 - 2018

N2 - Osteoporosis is a progressive systemic skeletal disease characterized by reduced bone density and disrupted microarchitecture of the bone tissue that leads to increased bone fragility and elevated risk of bone fractures. In osteoporotic condition decrease in bone density and strength happens not only due to the increased osteoclastic activity but also due to the decreased number of osteoblast cells precursors (mesenchymal stem cells) and development of so called “osteogenic insufficiency”. We proposed the new method of cell therapy with adipose derived mesenchymal stem cells (AT-MSCs) and surface modification with synthetic bisphosphonate osteophilic polymer that would restore the osteoblast progenitor pool and at the same time inhibit osteoclastic activity in the regeneration zone of osteoporosis associated fractures. In current paper we have outlined the process of osteophilic polymer synthesis, isolation of homogenic population of AT-MSCs and assessment of the purity of obtained cell populations, assessment of polymer effect on cell proliferation and subsequent differentiation down the osteogenic lineage and polymer effect on the osteoclastic activity in vitro. According to the obtained data polymer was not found to be cytotoxic and did not affect the speed of MSCs proliferation. Surface modification with the polymer has no effect on cell osteogenic differentiation however inhibits phagocytic activity of bone marrow derived macrophages. Polymer functionalized MSCs could be subsequently used in further animal studies to assess the efficacy of suggested approach for stimulation of regenerative processes in vivo using the animal model of osteoporosis and osteoporosis associated fractures of compact bones.

AB - Osteoporosis is a progressive systemic skeletal disease characterized by reduced bone density and disrupted microarchitecture of the bone tissue that leads to increased bone fragility and elevated risk of bone fractures. In osteoporotic condition decrease in bone density and strength happens not only due to the increased osteoclastic activity but also due to the decreased number of osteoblast cells precursors (mesenchymal stem cells) and development of so called “osteogenic insufficiency”. We proposed the new method of cell therapy with adipose derived mesenchymal stem cells (AT-MSCs) and surface modification with synthetic bisphosphonate osteophilic polymer that would restore the osteoblast progenitor pool and at the same time inhibit osteoclastic activity in the regeneration zone of osteoporosis associated fractures. In current paper we have outlined the process of osteophilic polymer synthesis, isolation of homogenic population of AT-MSCs and assessment of the purity of obtained cell populations, assessment of polymer effect on cell proliferation and subsequent differentiation down the osteogenic lineage and polymer effect on the osteoclastic activity in vitro. According to the obtained data polymer was not found to be cytotoxic and did not affect the speed of MSCs proliferation. Surface modification with the polymer has no effect on cell osteogenic differentiation however inhibits phagocytic activity of bone marrow derived macrophages. Polymer functionalized MSCs could be subsequently used in further animal studies to assess the efficacy of suggested approach for stimulation of regenerative processes in vivo using the animal model of osteoporosis and osteoporosis associated fractures of compact bones.

KW - osteoporosis

KW - osteoclasts

KW - reparative osteogenesis

KW - adipose mesenchymal stem cells

KW - osteophilic polymer

KW - cell therapy

UR - http://bb.kaznu.kz/index.php/biology/article/view/1364

M3 - Article

VL - 77

SP - 58

EP - 72

JO - Experimental Biology

JF - Experimental Biology

SN - 1563-0218

IS - 4 (2018)

ER -